<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser</title>
<style>
body { font-family: Arial, Helvetica, sans-serif; background:#0f1115; color:#e6e6e6; margin:0; padding:40px; }
.container { max-width:700px; margin:auto; background:#161a21; border-radius:10px; padding:32px; box-shadow:0 0 30px rgba(0,0,0,0.4); }
h1 { margin-top:0; color:#4da3ff; }
table { width:100%; margin-top:12px; border-collapse:collapse; }
th, td { text-align:left; padding:6px 8px; border-bottom:1px solid #2a2f3a; }
ul { margin-top:12px; padding-left:20px; }
.section { margin-top:24px; }
.small { margin-top:12px; font-size:13px; color:#999; }
a { color:#4da3ff; }
</style>
</head>
<body>
  <div class="container">
    <h1>Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser</h1>

    <table>
      <tr><th>Ticker</th><td>SSKN</td></tr>
      <tr><th>Float</th><td>3.9 M</td></tr>
      <tr><th>IO</th><td>19.32%</td></tr>
      <tr><th>MC</th><td>1.5 M</td></tr>
      <tr><th>Extra Info</th><td>None</td></tr>
    </table>

    <div class="section">
      <strong>Summary</strong>
      <p>STRATA Skin Sciences (NASDAQ: SSKN) announced that Johns Hopkins Dermatology has added the XTRAC® 308 nm excimer laser to its clinical offerings. The device will be used to treat chronic inflammatory and autoimmune skin diseases (psoriasis, vitiligo, atopic dermatitis) and to support ongoing clinical research and academic initiatives. The release highlights prior adoption of XTRAC by leading academic centers, cites over 300 peer‑reviewed studies supporting excimer therapy, and reiterates STRATA's partnership model (fee‑per‑treatment rather than equipment sale). No financial terms, purchase counts, or revenue impact were disclosed. A Safe Harbor statement notes forward‑looking risks and refers investors to the company's SEC filings.</p>
    </div>

    <div class="section">
      <strong>Positives</strong>
      <ul><li>Johns Hopkins Dermatology has added STRATA's XTRAC 308 nm excimer laser to clinical offerings</li><li>Device supports treatment of psoriasis, vitiligo, atopic dermatitis and other complex dermatologic conditions</li><li>Adds clinical and research validation by a leading academic medical center</li><li>STRATA emphasizes a partnership fee‑per‑treatment model that can support recurring revenue</li><li>XTRAC has prior adoption at multiple reputable institutions and a large peer‑reviewed evidence base</li></ul>
    </div>

    <div class="section">
      <strong>Negatives</strong>
      <ul><li>No financial terms, purchase order size, or expected revenue impact disclosed</li><li>No deployment timeline or commercial agreement details provided</li><li>Press release contains forward‑looking statements and references risks in SEC filings</li></ul>
    </div>

    <div class="section">
      <a href="https://news.nuntiobot.com/article/1f916a2c-a038-4a20-ba3b-a7bed9c83bd8" target="_blank">Original Article</a>
    </div>

    <div class="small">SSKN • TradersLink AI News</div>
  </div>
</body>
</html>